XPH Holdings Information

XPH is an equity ETF with a total of 60 individual holdings. The top holdings are Corcept Therapeutics stock at 4.22%, Organon & Co. at 3.65%, Liquidia at 3.10%, Axsome Therapeutics at 2.75%, and Enliven Therapeutics at 2.55%.

Total Holdings

Top 10 Percentage

27.77%

Asset Class

Equity

ETF Category

Health

Assets

342.67M

PE Ratio

14.96

Breakdown by Country

Top 25 Holdings

No.	Symbol	Name	% Weight	Shares
1	CORT	Corcept Therapeutics Incorporated	4.22%	184,776
2	OGN	Organon & Co.	3.65%	974,126
3	LQDA	Liquidia Corporation	3.10%	161,679
4	AXSM	Axsome Therapeutics, Inc.	2.75%	39,085
5	ELVN	Enliven Therapeutics, Inc.	2.55%	203,074
6	MBX	MBX Biosciences, Inc.	2.46%	211,997
7	TRVI	Trevi Therapeutics, Inc.	2.39%	522,141
8	DFTX	Definium Therapeutics, Inc.	2.28%	334,643
9	AMRX	Amneal Pharmaceuticals, Inc.	2.23%	490,512
10	JAZZ	Jazz Pharmaceuticals plc	2.13%	33,623
11	LGND	Ligand Pharmaceuticals Incorporated	2.07%	28,180
12	ESPR	Esperion Therapeutics, Inc.	2.05%	2,317,817
13	HRMY	Harmony Biosciences Holdings, Inc.	2.04%	216,548
14	NUVB	Nuvation Bio Inc.	2.02%	1,358,257
15	INDV	Indivior PLC	2.01%	189,899
16	RPRX	Royalty Pharma plc	2.00%	133,527
17	XERS	Xeris Biopharma Holdings, Inc.	1.99%	1,030,331
18	HROW	Harrow, Inc.	1.98%	168,769
19	VTRS	Viatris Inc.	1.96%	446,271
20	EWTX	Edgewise Therapeutics, Inc.	1.96%	201,172
21	LLY	Eli Lilly and Company	1.94%	6,235
22	ANIP	ANI Pharmaceuticals, Inc.	1.84%	81,719
23	PRGO	Perrigo Company plc	1.80%	635,516
24	AMLX	Amylyx Pharmaceuticals, Inc.	1.78%	417,574
25	OCUL	Ocular Therapeutix, Inc.	1.77%	656,253

Showing 25 of 60 holdings

Subscribe to see the full list

Activate Now

As of Jun 17, 2026